Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1055/s-0031-1300345 http://scihub22266oqcxt.onion/10.1055/s-0031-1300345 11190771!ä!11190771 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\11190771.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Arzneimittelforschung 2000 ; 50 (12): 1071-7 Nephropedia Template TP {{tp|p=11190771|t=2000. Progressionsverlauf experimentell ausgeloster arteriosklerotischer Gefasswandveranderungen nach Behandlung mit Magnesiumorotat |pdf=|usr=}}{{11190771}} gab.com Text Progressionsverlauf experimentell ausgeloster arteriosklerotischer Gefasswandveranderungen nach Behandlung mit Magnesiumorotat JO: Arzneimittelforschung http://www.kidney.de/pget.php?&tw=1&pmid=11190771 #FOAvip There are some experimental and clinical results regarding blood vessel protective properties of magnesium orotate (CAS 27067-77-2) till now. The goal of the present investigation was to verify the therapeutical efficacy of magnesium orotate vs. its singular components in cholesterol fed rabbits. Besides, the blood-lipid concentrations (LDL as risk factor for atherosclerosis and HDL as negative risk factor) were analyzed in relation to pathomorphological changes in the aortic blood vessel wall. The results of our experiments in New Zealand rabbits support the assumption that orotic acid and especially magnesium orotate influence the lipid level and/or the LDL/HDL-quotient in a favorable way and that they decrease the interaction between monocytes/macrophages and the endothelium of the blood vessels. Consequently, the plaque formation will be decreased in a clinically relevant manner. Twit Text FOAVip Progressionsverlauf experimentell ausgeloster arteriosklerotischer Gefasswandveranderungen nach Behandlung mit Magnesiumorotat ????Arzneimittelforschung http://www.kidney.de/pget.php?&tw=1&pmid=11190771 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=11190771 #FOAvip English Wikipedia <ref>{{Cite pmid|11190771}}</ref> Progressionsverlauf experimentell ausgeloster arteriosklerotischer Gefasswandveranderungen nach Behandlung mit Magnesiumorotat #MMPMID11190771 Jellinek H; Takacs E Arzneimittelforschung 2000[Dec]; 50 (12): 1071-7 PMID11190771show ga There are some experimental and clinical results regarding blood vessel protective properties of magnesium orotate (CAS 27067-77-2) till now. The goal of the present investigation was to verify the therapeutical efficacy of magnesium orotate vs. its singular components in cholesterol fed rabbits. Besides, the blood-lipid concentrations (LDL as risk factor for atherosclerosis and HDL as negative risk factor) were analyzed in relation to pathomorphological changes in the aortic blood vessel wall. The results of our experiments in New Zealand rabbits support the assumption that orotic acid and especially magnesium orotate influence the lipid level and/or the LDL/HDL-quotient in a favorable way and that they decrease the interaction between monocytes/macrophages and the endothelium of the blood vessels. Consequently, the plaque formation will be decreased in a clinically relevant manner. |Animals[MESH] |Anticholesteremic Agents/*therapeutic use[MESH] |Arteriosclerosis/*pathology/*prevention & control[MESH] |Blood Vessels/*pathology/ultrastructure[MESH] |Cholesterol, HDL/blood[MESH] |Cholesterol, LDL/blood[MESH] |Cholesterol/blood[MESH] |Diet, Atherogenic[MESH] |Disease Progression[MESH] |Endothelium, Vascular/pathology[MESH] |Male[MESH] |Microscopy, Electron[MESH] |Orotic Acid/*analogs & derivatives/*therapeutic use[MESH]Progressionsverlauf experimentell ausgeloster arteriosklerotischer Ge(epmc).pdf DeepDyve Pubget Overpricing